Hemp industry advocates are rejoicing after the Senate passed the Farm Bill yesterday in an 86-11 vote, legalizing the growing of commercial hemp on U.S. soil.
Photo © iStockphoto.com/AlenaPaulus
Hemp industry advocates are rejoicing after the Senate passed the Farm Bill yesterday in an 86-11 vote, legalizing the growing of commercial hemp on U.S. soil. Hemp industry representatives note that the Hemp Farming Act of 2018, which U.S. Senate Majority Leader Mitch McConnell (R-KY) introduced on April 12 and which was ultimately rolled up in the Senate's Farm Bill, made it through the Senate vote unchanged and with bipartisan support. Hemp will now be removed from Schedule I of the Controlled Substances Act, clearly separating it from marijuana, and will become an agricultural crop in the U.S. Hemp is also the source of the phytocannabinoid cannabidiol (CBD), an ingredient of growing interest in the dietary supplements industry.
Lobbyist group U.S. Hemp Roundtable, which celebrated yesterday's Senate Farm Bill passage, also cautioned that there is still work to be done to reconcile differences between the House and Senate versions of the Farm Bill. (The House passed its version of the Farm Bill on June 21.)
In an e-mail sent to industry supporters, the U.S. Hemp Roundtable warned, “A House/Senate conference committee will soon meet to resolve the differences between the Senate Farm Bill and the House Farm Bill, the latter which includes no hemp language. Senate Majority Leader Mitch McConnell will be leading the fight to ensure that the conference committee retains the hemp-friendly Senate language before it gets sent back to the House and Senate floors for final passage.” The group advocated supporters to contact their Senators and Congressmen to urge support of the hemp provisions of the Senate Farm Bill and created a portal on its website to facilitate communication.
Also read:
FDA Approves First Cannabis CBD Drug to Treat Severe Epilepsy
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Standardized valerian extract shows acute sleep benefits after one day, says recent study
December 10th 2024Results showed that after a single dose, people taking the Valerian extract experiences an acute benefit on sleep, namely a significant increase in actual sleep time compared to baseline.